Powered by

eGenesis Appoints Industry Veteran Paul Sekhri as President and Chief Executive Officer

Jan 17, 2019 - GlobeNewswire
Board and Executive Moves

CAMBRIDGE, Mass., Jan. 17, 2019 (GLOBE NEWSWIRE) -- eGenesis, a biotechnology company revolutionizing the field of transplantation with its multiplexed gene editing platform, today announced the appointment of Paul Sekhri as president and chief executive officer, effective immediately. Mr. Sekhri brings more than 25 years of experience in the life sciences industry, including executive management, global business development, drug development and commercial strategy. Mr. Sekhri succeeds Julie ...